Morgan Stanley says SpaceX plan implies potentially far more aggressive launches

Morning financial news flow across major Wall Street desks reflects a wide range of analyst rating adjustments, corporate earnings releases, and new commercial contract announcements. A central highlight includes Williams-Sonoma reporting second-quarter earnings per share of $2.10, topping the consensus estimate of $2.07, alongside updating its fiscal 2026 annual net revenue growth guidance to a range between 4.7% and 7.2%. Multiple brokerages also updated price targets across consumer and software names, including upward revisions for Five Below and Motorola Solutions. In the broader technology and enterprise software segments, analyst commentary focused on Broadcom's custom tensor processing unit market share and gross margin trajectory. Concurrently, Citigroup initiated an upside 90-day catalyst watch on Oracle following recent share pullbacks, while BridgeBio Pharma achieved a development milestone by dosing the first patient in its ASCEND-ATTR study. Major benchmark index ETFs reflected modest morning gains, displaying steady investor appetite across diverse industry sectors.